(Press-News.org) New York, NY (January 26, 2012) — Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the way for a genetic screening test to determine who can safely take these drugs. The study appears in the online version of the journal The Oncologist.
Oral bisphosphonates are currently taken by some 3 million women in the United States for the prevention or treatment of osteoporosis. In addition, intravenous bisphosphonates are given to thousands of cancer patients each year to control the spread of bone cancer and prevent excess calcium (hypercalcemia) from accumulating in the blood. Bisphosphonates work by binding to calcium in the bone and inhibiting osteoclasts, bone cells that break down the bone's mineral structure.
"These drugs have been widely used for years and are generally considered safe and effective," said study leader Athanasios I. Zavras, DMD, MS, DMSc, associate professor of Dentistry and Epidemiology and Director of the Division of Oral Epidemiology & Biostatistics at the Columbia University College of Dental Medicine. "But the popular literature and blogs are filled with stories of patients on prolonged bisphosphonate therapy who were trying to control osteoporosis or hypercalcemia only to develop osteonecrosis of the jaw."
Osteonecrosis of the jaw, or ONJ, often leads to painful and hard-to-treat bone lesions, which can eventually lead to loss of the entire jaw. Among people taking bisphosphonates, ONJ tends to occur in those with dental disease or those who undergo invasive dental procedures.
There are no reliable figures on the incidence of ONJ in patients taking oral bisphosphonates. Estimates range from 1 in 1,000 to 1 in 100,000 patients for each year of exposure to the medication, according to the American College of Rheumatology. ONJ is more common among cancer patients taking the intravenous form of the drug, affecting about 5 to 10 percent of these individuals, noted Dr. Zavras.
Studies have suggested that genetic factors play a major role in predisposing patients to ONJ.
Delving deeper into this question, Dr. Zavras and his colleagues performed genome-wide analyses of 30 patients who were taking bisphosphonates and had developed ONJ and compared them with several bisphosphonate users who were disease free.
The researchers found that patients who had a small variation in the RBMS3 gene were 5.8 times more likely to develop ONJ than those without the variation. The study also identified small variations in two other genes, IGFBP7 and ABCC4, that may contribute to ONJ risk.
"Our ultimate goal is to develop a pharmacogenetic test that personalizes risk assessment for ONJ, a test that you could give to people before they start to use bisphosphonates," said Dr. Zavras. "Those who are positive for this genetic variation would select some other treatment, while those who are negative could take these medications with little fear of developing ONJ."
"At the moment, many women discontinue or avoid treatment for serious osteoporosis because they are afraid of losing their jaw bones," added Dr. Zavras. "There even are reports of dentists who have refused to perform certain invasive procedures in patients taking bisphosphonates. So there is a great need for a pharmacogenetic screening test to determine which patients are really at risk for ONJ."
The current study looked only at Caucasians. Further studies are needed to determine whether the RBMS3 gene variation is seen in other racial groups, according to the researchers.
The paper is entitled, "Genome-wide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3." The lead authors are Paola Nicoletti of CUMC and Vassiliki M. Cartsos of Tufts School of Dental Medicine. The other contributors are Penelope K. Palaska of Tufts and Yufeng Shen and Aris Floratos at the Columbia University Medical Center Bioinformatics Department.
This research was supported by grant number 7R21DE018143-03 from the National Institute of Dental and Craniofacial Research.
Columbia University has filed a patent application with the United States Patent and Trademark Office relating to a genetic screening test for predisposition to ONJ, and, through its technology transfer office, Columbia Technology Ventures, is actively seeking partners to collaborate, license and commercialize the technology.
INFORMATION:
Columbia University College of Dental Medicine (CDM) was established in 1916 as the School of Dental and Oral Surgery, when the School became incorporated into Columbia University. The College's mission has evolved into a tripartite commitment to education, patient care, and research. The mission of the College of Dental Medicine is totrain general dentists, dental specialists, and dental assistants in a setting that emphasizes comprehensive dental care delivery and stimulates professional growth; inspire, support, and promote faculty, pre- and postdoctoral student, and hospital resident participation in research to advance the professional knowledge base; and provide comprehensive dental care for the underserved community of northern Manhattan. For more information, please visit: http://dental.columbia.edu/
Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia's College of Physicians and Surgeons was the first institution in the country to grant the M.D. degree and is among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest in the United States.
END
San Diego, January 26, 2012 - If you want to change how teenagers view bullying, go to the straight to the source of most school trends: the most connected crowd. According to new intervention research, targeting the most influential students in a school could be a key factor in reducing harassment and bullying.
These results are part of a group of studies that are being presented today at a social psychology conference in San Diego, CA, on new, sometimes small, ways to make meaningful impacts on people's lives. "This is an exciting time in the field of social psychology," ...
The staff of RiverEdge Dental are pleased to announce the addition of Dr. Andrea Mandelbaum to their practice.
Dr. Mandelbaum Smith studied at York University, where she earned an Honours degree with a major in Biology and a minor in Psychology. She then proceeded to obtain a , doctor of dental surgery, DDS degree from The University of Western Ontario in London. Dr. Mandelbaum chose her career path at the tender age of sixteen, at the urging of her own dentist. She currently resides in Maple with her husband and infant son. Dr. Mandelbaum brings a wealth of experience ...
HOUSTON -- (Jan. 26, 2012) -- Like a magician employing sleight of hand, the protein mitoNEET -- a mysterious but important player in diabetes, cancer and aging -- draws the eye with a flurry of movement in one location while the subtle, more crucial action takes place somewhere else.
Using a combination of laboratory experiments and computer modeling, scientists from Rice University and the University of California, San Diego (UCSD) have deciphered part of mitoNEET's movements to get a better understanding of how it handles its potentially toxic payload of iron and sulfur. ...
Karl Vanghen, author of 'My Enemy, My Beloved', has been named one of '50 Great Writers You Should Be Reading'. His honors came as a result of his appearance on The Authors Show. Vanghen was chosen from a field of hundreds of authors through a public voting process. 'My Enemy, My Beloved' is an historical fiction novel that explores the life of a German POW held on American soil.
"I wrote this book," stated Mr. Vanghen, "to reveal the life and times of German POW's and citizens swept up in World War Two. As a native Minnesotan, I, like many others, was ...
Cancer is one of the most common causes of death in humans. The conventional cancer therapies include surgery, radiotherapy, chemotherapy, and targeting therapies, which are intended to directly destroy and eliminate tumor cells. These treatments often fail, resulting in tumor metastasis and recurrence. Therefore, there is a critical need for novel cancer therapies. In recent years, an increasing number of studies have revealed that immune responses play a critical role in conventional cancer therapies. Replication-selective oncolytic viruses are a rapidly expanding therapeutic ...
IRS requires that employers need to furnish each employee a completed Form W-2, Wage and Tax Statement before Jan 31, 2012 mailing deadline. For 2012 tax season, employers can cut cost on the expensive pre-printed W-2 tax forms. Payroll tax software provider, Halfpricesoft.com (http://www.halfpricesoft.com) released the new ezW2 software, which can print all the W-2 forms on plain paper. The laser substitute forms of W-2 copy A and W-3 printed by ezW2 are SSA approved.
Available from just $39 per installation, ezW2 software has remained at that affordable price since ...
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK.
"There is currently no widely accepted standardized method for assessing symptom severity at exacerbations in COPD patients," said Dr Alex J Mackay, MBBS, MRCP, clinical research fellow at the Academic Unit of Respiratory Medicine, University College London. "Incorporating CAT scores into the assessment of COPD patients may provide a standardized, objective method for assessing symptom ...
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
"We found that LCI is elevated early in children with CF, especially in the presence of airway inflammation and Pseudomonas aeruginosa," said Yvonne Belessis, MBBS, MPH, PhD, respiratory staff specialist at the Sydney Children's Hospital. "LCI may not only be a marker of early CF lung disease, but may be useful as an objective outcome measure in future studies of young children with CF."
The ...
Label: Kusha Deep Records
Artist: Dar.Ra
Film and Music Title:
City Of Hope A Childrens Story
http://itunes.apple.com/gb/album/city-of-hope-ep/id498099383
The City Of Hope A Children's Story documentary is the tale of two American's Phillip Smith and his father Jack Smith, who have made amazing things happen for the street kids of Rio.
Their lives changed direction after they had sponsored a young Brazilian boy, and then witnessed the story 20/20 about the death squads in Rio and Sao Paulo.
Seeing the injustice and harsh reality that a birth into a poor family ...
MIAMI – Jan. 27, 2012 – In a study published in the journal Geology, scientists at the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science suggest that the large changes in the carbon isotopic composition of carbonates which occurred prior to the major climatic event more than 500 million years ago, known as 'Snowball Earth,' are unrelated to worldwide glacial events.
"Our study suggests that the geochemical record documented in rocks prior to the Marinoan glaciation or 'Snowball Earth' are unrelated to the glaciation itself," said UM Rosenstiel ...
